AIG
HOWL icon

American International Group’s Werewolf Therapeutics HOWL Stock Holding History

American International Group’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,111
Closed -$58K – 3171
2022
Q1 		$58K Sell
13,111
-923
-7% -$6.47K ﹤0.01% 2792
2021
Q4 		$167K Buy
14,034
+9,891
+239% +$149K ﹤0.01% 2464
2021
Q3 		$71K Sell
4,143
-98
-2% -$1.67K ﹤0.01% 2917
2021
Q2 		$74 Buy
+4,241
New +$58.1K ﹤0.01% 2942

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American International Group's HOWL Position: Q2 2022 in Review

American International Group sold out of Werewolf Therapeutics (HOWL) in Q2 2022, closing a stake of 13,111 shares — an estimated $58K sold.

American International Group first reported a position in HOWL in Q2 2021 and held it in 4 quarters. The position peaked at $167K in Q4 2021. 46 funds tracked by Wall St. Rank hold HOWL as of Q2 2022.

  • American International Group reported no remaining Werewolf Therapeutics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 13,111 Werewolf Therapeutics shares in Q2 2022, an estimated $58K.
  • American International Group first reported a position in Werewolf Therapeutics in Q2 2021 and held it in 4 quarters.
  • American International Group's Werewolf Therapeutics position peaked at $167K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.